1Getahun H, Harrington M, O'Brien R, et al. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes [ J ]. Lancet, 2007,369 (9578) : 2042 - 2049.
2Samb B, Sow PS, Kony S, et al. Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV semprevalence [J]. Int J Tuberc Lung Dis, 1999,3:330-336.
3Berlin OG, Young LS, Bruckner DA. In-vitro activity of six fluorinated quinolones against Mycobaeterium tuberculosis[J]. J Antimierob Chemothcr, 1987,19 : 611-615.
4Davies S, Sparham PD, Spencer RC. Comparative in-vitro activity of five fluoroquinolones against mycobacteria [J]. J Antimicrob Chemother, 1987,19:605-609.
6Hong YP, Kim S J, Lew WJ, et al. The seventh nationwide tuberculosis prevalence survey in Korea, 1995 [J]. Int J Tuberc Lung Dis, 1998,2:27-36.
7Yoon YS, Lee H J, Yoon HI, et al. Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia[J]. Int J Tuberc Lung Dis, 2005,9( 11 ) : 1215-1219.
8Siddiqi K, Lambert ML, WaUey J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence[J]. Lancet Infect Dis, 2003,3(5): 288-296.
